|Podcasts|September 13, 2021
From Lab to Life: Accelerating End-to-End Drug Development to Bring Medicines to Patients Faster
Author(s)Syneos Health
In Episode Two of the Syneos Health Dedicated Dialogue podcast series, we reveal how harnessing broad expertise across the product development lifecycle leads to relevant, effective and efficient solutions that speed commercial success and bring novel drugs to patients sooner to improve patient care.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
GSK Enters Multi-Year Collaboration with Helix to Develop Precision Medications
2
Pharmaceutical Executive Daily: Amgen Acquires Dark Blue Therapeutics for $840 Million
3
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
4
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences
5